Cancer News and Research

Latest Cancer News and Research

Researchers create computer algorithm to identify specific genes involved in breast cancer growth

Researchers from the University of Alberta and Alberta Health Services have created a computer algorithm that successfully predicts whether estrogen is sending signals to cancer cells to grow into tumours in the breast. By finding this hormone receptor, known as estrogen receptor positive, physicians can prescribe anti-estrogen drug therapies, improving patient outcomes.

3 Dec 2013

Scientists explain new family of proteins that appear to play key role in cancer

Scientists have described a new family of proteins that appear to play a key role in cancer and might be targets for future cancer drugs.

3 Dec 2013

Alliance HealthCare Services, ONRAD form strategic affiliation to provide quality services to customers

Alliance HealthCare Services, Inc., a leading national provider of radiology and radiation therapy services, and ONRAD, Inc., a full service radiology provider, have agreed to establish a strategic affiliation to develop and support opportunities to further enhance access to the quality services each company provides to its customers.

2 Dec 2013

Newly identified protein could prove promising new drug target for AIDS

Researchers have identified a protein that causes loss of function in immune cells combatting HIV. The scientists report in a paper appearing online Dec. 2 in the Journal of Clinical Investigation that the protein, Sprouty-2, is a promising target for future HIV drug development, since disabling it could help restore the cells' ability to combat the virus that causes AIDS.

2 Dec 2013

Study: Diet low in vitamin D can cause free radical damage in brain

A new study led by University of Kentucky researchers suggests that a diet low in vitamin D causes damage to the brain.

2 Dec 2013

Midurethral sling dominates female SUI treatment

Analysis of US data reveals that the midurethral sling for female stress urinary incontinence has been widely adopted over the past decade, and this is the primary reason for a decline in the use of traditional surgical techniques for the condition.

2 Dec 2013

Insomnia symptoms linked to increased mortality

Certain aspects of insomnia are associated with an increased risk for mortality, shows an analysis of a large cohort of US men.

2 Dec 2013

Four-drug regimen shows first-line efficacy in advanced NSCLC

A four-drug combination of cetuximab, bevacizumab, carboplatin, and paclitaxel is effective and has acceptable safety as a first-line treatment for advanced non-small-cell lung cancer, US researchers report.

2 Dec 2013

Xagenic announces closing of $20 million Series B financing

Xagenic Inc., a molecular diagnostics company developing the first lab-free molecular diagnostic platform with a 20 minute time-to-result, today announced the close of a Series B financing totaling $20 million. The round was led by new investor Domain Associates, LLC, which was joined by existing investors including CTI Life Sciences Fund and the Ontario Emerging Technologies Fund.

2 Dec 2013

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestations of chronic Graft-versus-Host disease.

2 Dec 2013

New biomarkers to improve diagnostics of prostate cancer

New biomarkers will improve diagnostics of endemic diseases in future, such as prostate cancer. Their mission: to recognize the tumor earlier and classify it more precisely - thereby helping avoid unnecessary operations.

2 Dec 2013

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing, today announces that it is launching a CE/IVD labeled MID kit for Illumina MiSeq together with three new germline mutation detection MASTRTM kits enabling the identification of individuals at risk for maturity onset diabetes of the young, autosomal dominant hypercholesterolemia, and hypertrophic cardiomyopathy.

2 Dec 2013

Cell Therapeutics gets $5 million payment from Teva for TRISENOX

Cell Therapeutics, Inc. today announced that it has received a $5 million milestone payment from Teva Pharmaceutical Industries Ltd. related to the achievement of a sales milestone for TRISENOX (arsenic trioxide).

2 Dec 2013

Special issue of JACR focuses on the role of imaging-based screening in preventive medicine

To be published online Monday, Dec. 2, a special issue of the Journal of the American College of Radiology addresses imaging-based screening and radiology's increasing role in preventive medicine. Topics covered include breast density legislation, digital breast tomosynthesis (or 3-D mammography), lung cancer screening and computed tomography colonography reimbursement.

2 Dec 2013

World-class Krembil Discovery Tower now opens in Canada

The Honourable Dr. K. Kellie Leitch, Minister of Labour and Minister of Status of Women congratulated Toronto Western Hospital today on the opening of the Krembil Discovery Tower, a facility dedicated to research excellence, training the next generation of medical professionals and improving health care for patients across Canada.

2 Dec 2013

Researchers discover promising new approach for colorectal cancer treatment

Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.

2 Dec 2013

Nanosponge vaccine blocks adverse effects of alpha-haemolysin toxin from MRSA

Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA-both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.

2 Dec 2013

GE Healthcare introduces new Invenia Automated Breast Ultrasound System at RSNA 2013

GE Healthcare, a unit of General Electric Company, introduced today the new Invenia Automated Breast Ultrasound System at the 2013 Radiological Society of North America annual meeting.

2 Dec 2013

Researchers examine how spindle apparatus self-organizes

Researchers at Waseda University in Japan have identified key information to help explain the formation of the "spindle apparatus", a structure required for cell division. Their findings shed light on the mechanisms behind "self-organization" - an essential characteristic of biological structures.

30 Nov 2013

Garden-Gateway believes chronic sufferers can cope with holiday stress

The holidays are a time of high stress for all of us. This is especially true for the many Californians who suffer from chronic illness or disease. It's well documented that stress can aggravate a wide range of chronic ailments, both physical and psychological, such as back pain, cancer, PTSD or immune system deficiency.

30 Nov 2013

Cancer News and Research

Latest Cancer News and Research

Researchers create computer algorithm to identify specific genes involved in breast cancer growth

Scientists explain new family of proteins that appear to play key role in cancer

Alliance HealthCare Services, ONRAD form strategic affiliation to provide quality services to customers

Newly identified protein could prove promising new drug target for AIDS

Study: Diet low in vitamin D can cause free radical damage in brain

Midurethral sling dominates female SUI treatment

Insomnia symptoms linked to increased mortality

Four-drug regimen shows first-line efficacy in advanced NSCLC

Xagenic announces closing of $20 million Series B financing

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

New biomarkers to improve diagnostics of prostate cancer

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

Cell Therapeutics gets $5 million payment from Teva for TRISENOX

Special issue of JACR focuses on the role of imaging-based screening in preventive medicine

World-class Krembil Discovery Tower now opens in Canada

Researchers discover promising new approach for colorectal cancer treatment

Nanosponge vaccine blocks adverse effects of alpha-haemolysin toxin from MRSA

GE Healthcare introduces new Invenia Automated Breast Ultrasound System at RSNA 2013

Researchers examine how spindle apparatus self-organizes

Garden-Gateway believes chronic sufferers can cope with holiday stress

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in